Bailard Lowered Its Thermo Fisher Scientific (TMO) Holding; Dynegy (DYN) Has 1.13 Sentiment

May 24, 2018 - By Hazel Jackson

Dynegy Inc. (NYSE:DYN) Logo

Dynegy Inc (DYN) investors sentiment decreased to 1.13 in Q4 2017. It’s down -0.39, from 1.52 in 2017Q3. The ratio turned negative, as 98 institutional investors started new and increased equity positions, while 87 decreased and sold equity positions in Dynegy Inc. The institutional investors in our database now hold: 135.98 million shares, up from 122.86 million shares in 2017Q3. Also, the number of institutional investors holding Dynegy Inc in top ten equity positions was flat from 7 to 7 for the same number . Sold All: 48 Reduced: 39 Increased: 53 New Position: 45.

Bailard Inc decreased Thermo Fisher Scientific Inc (TMO) stake by 56.18% reported in 2017Q4 SEC filing. Bailard Inc sold 17,968 shares as Thermo Fisher Scientific Inc (TMO)’s stock rose 8.51%. The Bailard Inc holds 14,015 shares with $2.66M value, down from 31,983 last quarter. Thermo Fisher Scientific Inc now has $87.18 billion valuation. The stock increased 0.07% or $0.16 during the last trading session, reaching $216.68. About 534,997 shares traded. Thermo Fisher Scientific Inc. (NYSE:TMO) has risen 33.66% since May 24, 2017 and is uptrending. It has outperformed by 22.11% the S&P500.

Investors sentiment decreased to 0.91 in Q4 2017. Its down 0.05, from 0.96 in 2017Q3. It dropped, as 43 investors sold TMO shares while 410 reduced holdings. 93 funds opened positions while 319 raised stakes. 335.65 million shares or 0.74% more from 333.20 million shares in 2017Q3 were reported. Tiemann Investment Advsrs Ltd reported 1,385 shares or 0.21% of all its holdings. Mairs And Power holds 0% or 1,460 shares. Private Advisor Gp Limited Liability Company owns 8,221 shares or 0.07% of their US portfolio. Edge Wealth Mgmt Ltd invested in 9 shares or 0% of the stock. Teachers Retirement Of The State Of Kentucky holds 0.2% or 89,833 shares in its portfolio. Nuveen Asset Lc has invested 0.02% in Thermo Fisher Scientific Inc. (NYSE:TMO). Longview Prns (Guernsey) accumulated 4.88M shares. First Long Island Investors Ltd Liability Corp accumulated 1,256 shares. Ameriprise Finance Inc holds 0.13% or 1.47M shares in its portfolio. Tradition Capital Management Limited Liability Company reported 27,642 shares. First Personal Financial Services accumulated 21,972 shares. Adell Harriman And Carpenter Inc has invested 0.19% of its portfolio in Thermo Fisher Scientific Inc. (NYSE:TMO). Tower Bridge holds 24,364 shares or 0.5% of its portfolio. Dodge Cox has 0.01% invested in Thermo Fisher Scientific Inc. (NYSE:TMO). E&G Advisors Lp has invested 0.1% in Thermo Fisher Scientific Inc. (NYSE:TMO).

Bailard Inc increased Global Blood Therapeutics In stake by 27,000 shares to 72,700 valued at $2.86M in 2017Q4. It also upped Vanguard Index Fds (VNQ) stake by 5,034 shares and now owns 122,423 shares. Itau Unibanco Hldg Sa (NYSE:ITUB) was raised too.

Since December 15, 2017, it had 0 insider buys, and 9 insider sales for $37.18 million activity. The insider Herrema Gregory J. sold 33,327 shares worth $7.32M. 6,000 shares were sold by Durbin Patrick M, worth $1.31M on Monday, February 5. The insider Williamson Stephen sold $511,511. CASPER MARC N sold $9.59M worth of stock or 50,000 shares. 1,000 shares were sold by Parrett William G, worth $209,796. Shares for $44,174 were sold by HARRIS C MARTIN.

Analysts await Thermo Fisher Scientific Inc. (NYSE:TMO) to report earnings on July, 25. They expect $2.69 EPS, up 16.96% or $0.39 from last year’s $2.3 per share. TMO’s profit will be $1.08B for 20.14 P/E if the $2.69 EPS becomes a reality. After $2.50 actual EPS reported by Thermo Fisher Scientific Inc. for the previous quarter, Wall Street now forecasts 7.60% EPS growth.

Among 19 analysts covering Thermo Fisher Scientific (NYSE:TMO), 18 have Buy rating, 0 Sell and 1 Hold. Therefore 95% are positive. Thermo Fisher Scientific had 63 analyst reports since July 24, 2015 according to SRatingsIntel. The rating was maintained by Jefferies on Thursday, March 30 with “Hold”. The company was maintained on Friday, April 28 by Leerink Swann. Jefferies maintained it with “Hold” rating and $205.0 target in Friday, October 20 report. The stock has “Buy” rating by Argus Research on Tuesday, October 6. Barclays Capital maintained it with “Overweight” rating and $245 target in Thursday, February 1 report. The rating was maintained by Morgan Stanley on Thursday, February 1 with “Overweight”. The firm has “Overweight” rating by Morgan Stanley given on Wednesday, April 11. The company was initiated on Thursday, January 7 by Deutsche Bank. The firm has “Buy” rating by Mizuho given on Tuesday, May 3. The firm has “Buy” rating by Stifel Nicolaus given on Monday, January 11.

Another recent and important Thermo Fisher Scientific Inc. (NYSE:TMO) news was published by Seekingalpha.com which published an article titled: “Key events next week – healthcare” on May 18, 2018.

Bain Capital Credit Lp holds 8.53% of its portfolio in Dynegy Inc. for 815,766 shares. Farmstead Capital Management Llc owns 1.02 million shares or 8.08% of their US portfolio. Moreover, New Generation Advisors Llc has 4.64% invested in the company for 636,700 shares. The Connecticut-based Mcclain Value Management Llc has invested 4.21% in the stock. Lasry Marc, a New York-based fund reported 1.72 million shares.

The stock decreased 2.51% or $0.33 during the last trading session, reaching $12.81. About 22.18M shares traded or Infinity% up from the average. Dynegy Inc. (DYN) has risen 79.34% since May 24, 2017 and is uptrending. It has outperformed by 67.79% the S&P500.

Dynegy Inc., through its subsidiaries, produces and sells electric energy, capacity, and ancillary services in the United States. The company has market cap of $1.85 billion. It operates in six divisions: PJM, NY/NE, ERCOT, MISO, IPH, and CAISO. It currently has negative earnings. The firm sells its services on a wholesale basis from its power generation facilities.

Thermo Fisher Scientific Inc. (NYSE:TMO) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


>